Sedation for uncontrolled symptoms in a South African hospice

Journal of Pain and Symptom Management

Volumn 16, Issue 3, 1998, Pages 145-152

  Fainsinger, Robin L ^a,c   Landman, Willie ^b   Hoskings, Mark ^b   Bruera, Eduardo ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b St Luke's Hospice   (South Africa)

^c ROYAL ALEXANDRA HOSPITAL   (Canada)

Author keywords

Delirium; Dyspnea; Hospice; Sedation; Terminal illness

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; LORAZEPAM; MIDAZOLAM; MORPHINE; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DELIRIUM; DOSE RESPONSE; FEMALE; HOSPICE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEDICAL ETHICS; PREVALENCE; SEDATION; SOUTH AFRICA; TERMINAL DISEASE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPICE CARE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 0032167613     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(98)00066-9     Document Type: Article

References (31)

1. 1. Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 1994;10:31-38.
2. 2. Billings JA, Block SD. Slow euthanasia. J Palliat Care 1996;12:21-30.
3. 3. Fonderas J. Sedation and ethical contradiction. Eur J Palliat Care 1996;3:17-20.
4. 4. Paterson J, Chater S. Terminal sedation. Knoll Pain Management Newsletter 1997;10:1-2.
5. 5. Twycross RG. Symptom control: the problem areas. Palliat Med 1993;7:1-8.
6. 6. Burke AL, Diamond PL, Hulbert J, Yeatman J, Farr EA. Terminal restlessness - its management and the role of midazolam. Med J Aust 1991;155: 485-487.
7. 7. Ventafridda V, Ripamonti C, deConno F, et al. Symptom prevalence and control during cancer patients last days of life. J Palliat Care 1990;6:7-11.
8. 8. McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 1994;9:341-345.
9. 9. Morita T, Inoue S, Chihara S. Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Manage 1996;12:32-38.
10. 10. Sanders H, Smales L. Discomfort and pain associated with paratonia. Eur J Palliat Care 1996;3:54-55.
11. 11. Stone P, Phillips C, Spruit O, Waight C. A comparison of the use of sedatives in a hospital support team and in hospice. Palliat Med 1997;11:140-144.
12. 12. de Stoutz ND, Tapper M, Fainsinger RL. Reversible delirium in terminally ill patients. J Pain Symptom Manage 1995;10:249-253.
13. 13. de Stoutz ND, Bruera E, Suraez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995;10:378-384.
14. 14. Bruera E, Franco JJ, Maltoni M, Watanabe S, Suraez-Almazor M. Changing pattern of agitated impaired mental status in patients with advanced cancer: Association of cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage 1995; 10:287-291.
15. 15. Fainsinger RL, Bruera E. The management of dehydration in terminally ill cancer patients. J Palliat Care 1994;10:55-59.
16. 16. Fainsinger RL, Tapper M, Bruera E. A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliative Care 1993;9:4-8.
17. 17. Cancer Pain: A monograph on the management of cancer pain. Health and Welfare Canada: Ministry of Supply and Services Canada, Ottawa, H42-2/5 1984E.
18. 18. SAS/STAT Version 6, 4th Edition, Cary, North Carolina: SAS Institute Inc., 1990;846.
19. 19. Fainsinger R, Bruera E, Miller MJ, Hanson J, MacEachern T. Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991;7:5-11.
20. 20. Stiefel F, Fainsinger R, Bruera E. Acute confusional states in patients with advanced cancer. J Pain Symptom Manage 1992;7:94-98.
21. 21. Mount BM. Morphine drips, terminal sedation, and slow euthanasia: definitions and facts, not anecdotes. J Palliat Care 1996;12:31-37.
22. 22. Brody H. Commentary on Billings and Block's "Slow Euthanasia." J Palliat Care 1996;12:38-41.
23. 23. Dickens BM. Commentary on "Slow Euthanasia." J Palliat Care 1996;12:42-43.
24. 24. Portenoy RK. Morphine infusions at the end of life: the pitfalls in reasoning from anecdote. J Palliat Care 1996;12:44-46.
25. 25. Dunlop RJ. Is terminal restlessness sometimes drug induced? Palliat Med 1989;3:65-66.
26. 26. Holdsworth MT, Adams VR, Chavez CM, et al. Continuous midazolam infusion for the management of morphine-induced myoclonus. Ann Pharmacother 1995;29:25-29.
27. 27. Bruera E, Fainsinger R, Miller MJ, Kuehn N. The assessment of pain intensity in patients with cognitive failure: a preliminary report. J Pain Symptom Manage 1992;7:267-270.
28. 28. Coyle N, Breitbalt W, Weaver S, Portenoy R. Delirium as a contributing factor to "crescendo" pain: three case reports. J Pain Symptom Manage 1994;9: 44-47.
29. 29. Pereira J, Hanson J, Bruera E. The frequency and clinical cause of cognitive impairment in patients with terminal cancer. Cancer 1997;79:835-842.
30. 30. Fainsinger RL, Bruera E. When to treat dehydration in a terminally ill patient? Support Care Cancer 1997;5:205-211.
31. 31. Fainsinger R, Bruera E. Case report: is this opioid analgesic tolerance? J Pain Symptom Manage 1995;10:573-577.